A prospective study on clinical efficacy of anti-allergic medical therapy and nitric oxide levels in patients with allergic rhinitis.

A prospective study on clinical efficacy of anti-allergic medical therapy and nitric oxide levels in patients with allergic rhinitis. - Clinical efficacy of anti-allergic medical therapy and nitric oxide levels in patients with allergic rhinitis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016536

Enrollment

110

Registered

2015-04-01

Start date

2015-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

Medical treatment in AR patients with moderate symptoms for 8 weeks. Medical treatment in AR patients with severe symptoms for 8 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: symptomatic allergic rhinitis patients

Exclusion criteria

Exclusion criteria: patients with other systemic diseases who fail to participate in the treatment schedule pregnant patients patients with previous sinus surgery

Design outcomes

Primary

Measure	Time frame
subjective symptoms and clinical findings	—

Secondary

Measure	Time frame
nitric oxide levels	—

Countries

Japan

Contacts

Public ContactSachio Takeno

Hiroshima University Department of Otorhinolaryngology

takeno@hiroshima-u.ac.jp082-257-5252

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026